Immix Biopharma, Inc. (IMMX)
Nasdaq: IMMX · Pharmaceutical Preparations · Los Angeles, CA · filing with the SEC since 2021
Who runs Immix Biopharma, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Rachman Ilya M
CEO and Chairman. First filing Dec 2021, latest May 29, 2026, 8 filings in all.
Officers reporting now
2
of 9 people with a filing in the last fifteen months
Directors reporting now
7
11 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Rachman Ilya M | CEO and Chairman | Dec 2021 | May 29, 2026 | none |
| Morris Gabriel S | CFO, President | Dec 2021 | May 29, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Adams Helen C. | director | Dec 2021 | May 29, 2026 | none |
| Buchan Melissa Jane | director | Dec 2021 | May 29, 2026 | none |
| Chang Nancy T | director | Sep 2025 | May 29, 2026 | none |
| Chudnovsky Yekaterina | director | Aug 2023 | May 29, 2026 | none |
| Hsu Jason | director | Dec 2021 | May 29, 2026 | none |
| Marquet Magda | director | Dec 2021 | May 29, 2026 | none |
| Ng Carey | director | Dec 2021 | May 29, 2026 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.